Yüklüyor......
Bitter melon extracts enhance the activity of chemotherapeutic agents through the modulation of multiple drug resistance
Recently we demonstrated that extracts of bitter melon (BME) can be used as a preventive/therapeutic agent in colon cancers. Here, we determined BME effects on anticancer activity and bioavailability of doxorubicin (DOX) in colon cancer cells. BME enhanced the effect of DOX on cell proliferation and...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3939049/ https://ncbi.nlm.nih.gov/pubmed/24129966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jps.23753 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|